申请人:AbbVie Inc.
公开号:US20160355482A1
公开(公告)日:2016-12-08
Compounds of formula (I)
and pharmaceutically acceptable salts, esters, amides, or radiolabelled forms thereof, wherein R
1
, R
2
, and R
3
are as defined in the specification, are useful in treating conditions or disorders prevented by or ameliorated by voltage-gated sodium channels, e.g., Na
v
1.7 and/or Na
v
1.8. Methods for making the compounds are disclosed. Also disclosed are pharmaceutical compositions of compounds of formula (I), and methods for using such compounds and compositions.